Publication Ethics and Publication Mulpractice Statement
Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors ( http://www.icmje.org/recommendations/ )
The Editorial Board Members of the Journal accept to follow 'Editorial Policy' of the 'Council of Science Editors' https://www.councilscienceeditors.org/resource-library/editorial-policies/white-paper-on-publication-ethics/2-1-editor-roles-and-responsibilities/#2112ref ) and the guidelines provided by the Committee on Publication Ethics (COPE) ( https://publicationethics.org/files/General_Approach_To_Publication_Ethics_For_Editorial_Office.pdf ) , the International Committee of Medical Journal Editors (ICMJE) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.
Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki ( https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ ) is required for experimental, clinical, and drug studies and for some case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors.
If there is any concern or dispute at over the stıdies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.